公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions | CHUN-TA HUANG ; SHENG-YUAN RUAN ; WEI-YU LIAO ; YAO-WEN KUO ; Lin C.-Y.; Tsai Y.-J.; CHAO-CHI HO ; CHONG-JEN YU | PLoS ONE | 26 | 25 | |
2020 | Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids | Huang T.-M.; Kuo K.-C.; Wang Y.-H.; Wang C.-Y.; Lai C.-C.; HAO-CHIEN WANG ; Chen L.; CHONG-JEN YU | BMC Infectious Diseases | 16 | 12 | |
2019 | Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists | Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; HAO-CHIEN WANG ; Chen L.; CHONG-JEN YU ; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG ; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; CHUNG-YU CHEN ; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) | Aging | 7 | 6 | |
2019 | Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers | Lai C.-C.; Wang Y.-H.; Wang C.-Y.; HAO-CHIEN WANG ; CHONG-JEN YU ; Chen L.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) | Critical Care Medicine | 13 | 12 | |
2016 | Risk of tuberculosis among patients on dialysis | CHIN-CHUNG SHU ; CHIA-LIN HSU ; Wei Y.-F.; CHIH-YUAN LEE ; Liou H.-H.; VIN-CENT WU ; FENG-JUNG YANG ; HSIEN-HO LIN ; JANN-YUAN WANG ; JIN-SHING CHEN ; CHONG-JEN YU ; LI-NA LEE | Medicine (United States) | 17 | 14 | |
2018 | Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation | Wang, Ya-Hui; Lai, Chih-Cheng; Wang, Cheng-Yi; HAO-CHIEN WANG ; CHONG-JEN YU ; Chen, Likwang; Taiwan Clinical Trial Consortium for Respiratory Diseases | Journal of clinical medicine | 1 | 1 | |
2012 | RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer | TZU-HSIU TSAI ; KANG-YI SU ; SHANG-GIN WU ; YIH-LEONG CHANG ; Luo S.-C.; Jane I.-S.; CHONG-JEN YU ; Yue S.-L.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 42 | 37 | |
2009 | The role of chest radiography in the suspicion for and diagnosis of pulmonary tuberculosis in intensive care units | Wu J-Y.; SHIH-CHI KU ; CHIN-CHUNG SHU ; Fan J-Y.; Chen H-Y.; Chen Y-C.; CHONG-JEN YU | International Journal of Tuberculosis and Lung Disease | 11 | 10 | |
2016 | The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Scientific Reports | 32 | 28 | |
2007 | Role of the renin-angiotensin system in ventilator-induced lung injury: An in vivo study in a rat model | JIH-SHUIN JERNG ; Hsu Y.-C.; HUEY-DONG WU ; Pan H.-Z.; HAO-CHIEN WANG ; CHIA-TUNG SHUN ; CHONG-JEN YU ; PAN-CHYR YANG | Thorax | 71 | 64 | |
2012 | Safety and immunogenicity of a split-virion AS03 A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults | PAN-CHYR YANG ; CHONG-JEN YU ; SHAN-CHWEN CHANG ; SZU-MIN HSIEH ; Drame M.; Walravens K.; Roman F.; Gillard P. | Journal of the Formosan Medical Association | 9 | 9 | |
2009 | Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens | CHAO-CHI HO ; YEE-CHUN CHEN ; Hu F.-C.; CHONG-JEN YU ; PAN-CHYR YANG ; KWEN-TAY LUH | Clinical Infectious Diseases | 44 | 35 | |
2014 | Safety of rifabutin replacing rifampicin in the treatment of tuberculosis: A single-centre retrospective cohort study | JUNG-YIEN CHIEN ; Chien S.; Huang S.; CHONG-JEN YU | Journal of Antimicrobial Chemotherapy | 29 | 24 | |
2010 | Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer | Wu J.-Y.; JIN-YUAN SHIH ; CHIH-HSIN YANG ; KUAN-YU CHEN ; CHAO-CHI HO ; CHONG-JEN YU ; PAN-CHYR YANG | International Journal of Cancer | 53 | 45 | |
2021 | Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC | BIN-CHI LIAO ; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHING-YAO YANG ; TZU-HSIU TSAI ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; Soo, Ross A; CHIH-HSIN YANG | JTO clinical and research reports | 2 | 0 | |
2013 | Sero-diagnosis of mycobacterium avium complex lung disease using serum immunoglobulin a antibody against glycopeptidolipid antigen in Taiwan | CHIN-CHUNG SHU ; Ato M.; JANN-TAY WANG ; Jou R.; JANN-YUAN WANG ; Kobayashi K.; HSIN-CHIH LAI ; CHONG-JEN YU ; LI-NA LEE ; KWEN-TAY LUH | PLoS ONE | 27 | 23 | |
1997 | Serodiagnosis of tuberculosis: A study comparing three specific mycobacterial antigens | Chiang I.-H.; Suo J.; Bai K.-J.; Lin T.-P.; KWEN-TAY LUH ; CHONG-JEN YU ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 79 | 64 | |
2021 | Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003 | WEN-PIN TSENG ; JHONG-LIN WU ; Chen-Chi Wu ; KUAN-TING KUO ; CHIEN-HAO LIN ; Yang, Bey-Jing; Huang, Chien-Hua; CHIEN-HUA HUANG ; Huang, Chien-Hua; SHEY-YING CHEN ; CHONG-JEN YU ; SHYR-CHYR CHEN ; PO-REN HSUEH | Frontiers in immunology | 10 | 5 | |
2010 | Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: A prospective observational cohort study | Lin M.-T.; Wei Y.-F.; SHIH-CHI KU ; Lin C.-A.; CHAO-CHI HO ; CHONG-JEN YU | Journal of the Formosan Medical Association | 7 | 7 | |
2001 | Severe community-acquired pneumonia due to Acinetobacter baumannii | Chen M.-Z.; PO-REN HSUEH ; LI-NA LEE ; CHONG-JEN YU ; PAN-CHYR YANG ; KWEN-TAY LUH | Chest | 141 | 110 |